The AccuProbe chemiluminescent culture identification test for Neisseria gonorrhoeae (Gen-Probe Inc., San Diego, Calif.) was assessed in a comparative evaluation with other rapid methods by using 269 
Several commercial identification systems based on a variety of biochemical and immunological methods are available for the rapid identification of Neisseria gonorrhoeae (3) . Recently, DNA probe technology has created new diagnostic approaches for use in the clinical laboratory (8, 20, 23) . Several tests have now been developed for the direct detection of target sequences of N. gonorrhoeae either in patient exudates (5, 6, 13, 18, 19) as a means of noncultural diagnosis or in cultured organisms (1, 11, 12, 16, 22) to provide confirmatory identification. Probes based on target sequences of chromosomal DNA have been evaluated most extensively as identification tests, but with a few exceptions (11) , they have given problems with specificity (1, 16, 22) and sensitivity (22) . DNA probes can also be derived from rRNA (4) , and this approach has been used in the AccuProbe culture identification test for N. gonorrhoeae (Gen-Probe Inc., San Diego, Calif.). The AccuProbe test uses a chemiluminescent labelled single-stranded DNA probe that is complementary to gonococcal rRNA. Test bacteria are lysed to release the rRNA, which, in the case of gonococci, combines with the DNA probe to form a stable DNA-RNA hybrid. A selection reagent differentiates between the nonhybridized and the hybridized probes. The labelled DNA-RNA hybrids are measured in a Gen-Probe luminometer, and the results are expressed as relative light units (RLUs). A prototype AccuProbe identification test demonstrated 100% sensitivity and specificity (12) . We report a comparative evaluation of a commercially available Gen-Probe kit with other rapid methods for the identification of N. gonorrhoeae.
MATERIALS AND METHODS
A total of 269 isolates of oxidase-positive, gram-negative diplococci were included in the study. These comprised strains submitted to the Scottish Gonococcal Reference Laboratory for gonococcal serotyping and antibiotic suscep-* Corresponding author. tibility testing, unselected oxidase-positive, gram-negative diplococci isolated in our laboratory from cultures of anogenital and throat specimens from patients undergoing screening for gonococcal infection or from cultures of throat swabs that were requested for routine culture, and a strain of Neisseria cinerea from the National Collection of Type Cultures (NCTC 10294). All isolates were subcultured onto modified New York City medium (25) lacking selective antibiotics, incubated overnight at 37°C, and used as the inoculum for the following identification procedures, which were performed in parallel.
The rapid carbohydrate utilization test (RCUT) was performed by using in-house reagents as described previously (25, 28) , but microwell strips rather than individual tubes were used. Each strip included wells for glucose, maltose, sucrose, lactose, fructose, and ampicillin in a buffer containing phenol red pH indicator. Results were read after 3 h of incubation at 37°C. The Phadebact Monoclonal GC test (Kara Bio Diagnostics AB, Huddinge, Sweden) was performed according to the manufacturer's instructions. This coagglutination test uses two reagents comprising pools of murine monoclonal antibodies that are reactive with epitopes on isolates with proteins IA (WI reagent) and IB (WII/III reagent), respectively. A boiled suspension of the test organism was tested against each reagent, and results were read within 1 min as described previously (26) . The API Quadferm system (Bio Merieux, Marcy-l'Etoile, France) is a standardized system for the rapid identification of Neisseria and Branhamella species and the determination of penicillinase activity. Each test strip contains seven microcupules comprising a control well and glucose, maltose, lactose, sucrose, DNase, and penicillinase test wells.
Test strips were inoculated, incubated, and read after 2 h according to the manufacturer's instructions. The AccuProbe N. gonorrhoeae culture confirmation test (Gen-Probe) was performed according to the manufacturer's instructions. For each specimen, a 1-,ul loopful of cells or several (three to four) small colonies was transferred to a probe reagent tube 23 .5 times (range, 11 to 150 times) the mean PLU for nongonococcal organisms. These results confirm the 100% sensitivity and specificity found in the evaluation of the prototype AccuProbe kit by using the Leader I luminometer (12) . The differentiation was, however, slightly greater in the latter study; the mean RLU for gonococci was 21.7 times (range, 1.7 to 33.4 times) above the cutoff (50,000) for a positive result, while values for nongonococcal organisms ranged from 181.8 times (for a strain of N. meningitidis) to 5.6 times (for a strain of N. cinerea) below the cutoff. Harada et al. (7) reported a significant correlation between the AccuProbe result in terms of RLUs and the number of gonococci (r = 0.96); the threshold of detection was 5 x 103 CFU per tube. The sensitivity of detection of gonococci was not influenced by the presence of other bacteria (7) , although endogenous RNase activity may decrease the RLU by 43 to 71% when cultures are incubated for 96 h (12) . This decrease did not result in a decrease in the RLUs given by any of the gonococci below the cutoff.
Nevertheless, the manufacturer recommends that colonies should be less than 48 h old.
Because the strains evaluated in the present study include isolates that were negative by other test systems, the absolute sensitivity of AccuProbe is particularly reassuring. Serovar IB-17 has previously been reported to be negative in the Phadebact Monoclonal GC test (26) . However, because the prevalence of this serovar is low in most geographical areas (14, 27) The absolute specificity of AccuProbe is also reassuring because of difficulties that have been encountered in differentiating between N. cinerea and N. gonorrhoeae (2, 10) . In one case, this resulted in proctitis associated with N. cinerea being misdiagnosed as a gonococcal infection in an 8-yearold boy (4) . The failure of some strains of meningococci to give a positive reaction in certain biochemical test systems (21) has resulted in colonization with "maltose-negative" meningococci being misdiagnosed as pharyngeal gonorrhoea (17) . The high sensitivity and specificity of AccuProbe suggest that the same test principle may be of considerable value in detecting gonococci in patient exudates. Preliminary reports of direct detection in high-prevalence (21 to 24%) populations with the Gen-Probe PACE assay gave a sensitivity of approximately 90 to 93% and a specificity of 99% (5, 6) . In a comparison of Gen-Probe PACE 2 with transported Gen-Probe swabs and conventional culture based on JEM-BEC plates incubated overnight prior to spending a minimum of 2 days in the mail system, 2.7% of specimens were positive by the probe method and 0.6% were positive by culture; indirect evidence suggested that the probe-positive, culture-negative specimens were false-negative cultures (13) . Evaluations involving optimal culture procedures and low-prevalence populations are, however, lacking. The limit of detection of 5 x 103 CFU per tube by AccuProbe is severalfold in excess of the mean number of gonococci found in cervical aspirates (1 x 106 CFU/ml) and is similar to the minimum of the culture-positive range (5 x 103 to 8 x 106) (29) . This supports the probability of good sensitivity, provided that an adequate sample is obtained.
We conclude that the AccuProbe culture confirmation test provides a rapid (total time, 30 min, with 5 to 10 min of hands-on time) and accurate objective means of identifying cultured N. gonorrhoeae. We have not evaluated the test using primary cultures, but the finding of Harada et al. (7) that detection sensitivity was not influenced by the presence of other bacteria suggests that this procedure should give similar results. Like immunological test systems, the probe test does not characterize nongonococcal neisserial isolates to the species level. We do not consider this to be an important factor in test selection in those laboratories whose main aim is to detect or exclude patients with gonococcal infections.
